Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? - PubMed (original) (raw)
Comparative Study
. 2002 Apr 15;94(8):2282-7.
doi: 10.1002/cncr.10457.
Affiliations
- PMID: 12001128
- DOI: 10.1002/cncr.10457
Free article
Comparative Study
Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
Emily B Smith et al. Cancer. 2002.
Free article
Abstract
Background: With the advent of the prostate specific antigen (PSA) assay, an increased detection rate of prostate carcinoma has ensued. This has been associated with a downward stage migration. In contrast, grade has shifted heavily toward moderate differentiation. The authors sought to test the hypothesis that such changes in grade in part may be because of trends among pathologists to upgrade similar specimens over time.
Methods: Two expert genitourinary pathologists regraded 23 prostate biopsies and 15 radical prostatectomy specimens during a 3-year period (1989-1991). Each pathologist then regraded 32 prostate biopsies and 15 radical prostatectomies from 1998 to 2000. For both time periods, each pathologist regraded only specimens that they personally had graded initially. All specimens were scored using the Gleason system, the predominant system used in describing prostate carcinoma grade. In evaluating original and regraded scores, the authors classified score changes between less than or equal to 6 and greater than or equal to 7 or between 7 and greater than or equal to 8 as significant because such changes have a high probability of altering clinical management. The results were analyzed using the two-tailed Fisher exact test.
Results: Of 23 prostate biopsies from 1989 to 1991, 10 of 23 (44%) had a clinically significant Gleason score change when regraded, whereas 2 of 15 (13%) radical prostatectomy specimens from the same period had a clinically significant Gleason score change. A significant change in the distribution of biopsy Gleason scores on regrading was observed (P < 0.04). In comparison, when the prostate biopsies from 1998-2000 were regraded, 10 of 32 (31%) had a clinically significant grade change. Radical prostatectomy specimens from the same period revealed 3 of 15 (20%) with a clinically significant grade change. After regrading the biopsies from 1989-1991, 8 of 23 (35%) of were upgraded, whereas 2 of 23 (9%) were downgraded. In comparison, of the biopsies with significant changes from 1998 to 2000, 3 of 32 (9%) were upgraded, whereas 7 of 32 (22%) were downgraded. Of the radical prostatectomy specimens with significant change, only 2 of 15 from each period were upgraded. Significant upgrading (P < 0.005) occurred only in the biopsy specimens from 1989 to 1991.
Conclusions: The authors' data suggest that rates of upgrading and downgrading of biopsy specimens differ between the 1989-1991 cases and the 1998-2000 cases, with the 1989-1991 samples exhibiting a significant change toward higher grades. Although not excluding the possibility of a change in the biology of prostate carcinoma over time, these findings suggest that the apparent trend toward higher biopsy grades in part may be because of how pathologists interpret these specimens today as compared with 10 years ago. Therefore, outcome studies including a biopsy Gleason score from older specimens as a risk variable have a significant chance of being vulnerable to this phenomenon. Based on the authors' data, all such specimens should undergo rereview.
Copyright 2002 American Cancer Society.
Similar articles
- Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR, McNeal JE, Gill H, Presti JC Jr. King CR, et al. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145152 - Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H. Divrik RT, et al. Urol Oncol. 2007 Sep-Oct;25(5):376-82. doi: 10.1016/j.urolonc.2006.08.028. Urol Oncol. 2007. PMID: 17826653 - Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA. Zhou M, et al. J Urol. 2001 Dec;166(6):2193-7. J Urol. 2001. PMID: 11696734 - Prostate biopsy: who, how and when. An update.
Djavan B, Milani S, Remzi M. Djavan B, et al. Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review. - Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.
Montironi R, Mazzuccheli R, Scarpelli M, Lopez-Beltran A, Fellegara G, Algaba F. Montironi R, et al. BJU Int. 2005 Jun;95(8):1146-52. doi: 10.1111/j.1464-410X.2005.05540.x. BJU Int. 2005. PMID: 15877724 Review.
Cited by
- Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label.
Semsarian CR, Ma T, Nickel B, Barratt A, Varma M, Delahunt B, Millar J, Parker L, Glasziou P, Bell KJL. Semsarian CR, et al. Prostate. 2023 May;83(6):498-515. doi: 10.1002/pros.24493. Epub 2023 Feb 22. Prostate. 2023. PMID: 36811453 Free PMC article. Review. - Survival analysis of patients with biochemical relapse after radical prostatectomy treated with androgen deprivation: Castration-resistance influential factors.
Algarra R, Hevia M, Tienza A, Merino I, Velis JM, Zudaire J, Robles JE, Pascual I. Algarra R, et al. Can Urol Assoc J. 2014 May;8(5-6):E333-41. doi: 10.5489/cuaj.1665. Can Urol Assoc J. 2014. PMID: 24940460 Free PMC article. - Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
King SC, Pollack LA, Li J, King JB, Master VA. King SC, et al. J Urol. 2014 Jun;191(6):1665-70. doi: 10.1016/j.juro.2013.12.046. Epub 2014 Jan 11. J Urol. 2014. PMID: 24423441 Free PMC article. - The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy.
Majoros A, Szász AM, Nyirády P, Székely E, Riesz P, Szendrői A, Keszthelyi A, Kulka J, Romics I. Majoros A, et al. Int Urol Nephrol. 2014 Feb;46(2):371-7. doi: 10.1007/s11255-013-0538-4. Epub 2013 Aug 30. Int Urol Nephrol. 2014. PMID: 23990495 - Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea.
Kim D, Choi D, Lim JH, Yoon JH, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Kim D, et al. Korean J Urol. 2012 Oct;53(10):680-5. doi: 10.4111/kju.2012.53.10.680. Epub 2012 Oct 19. Korean J Urol. 2012. PMID: 23136627 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous